| Product NDC: | 55505-137 |
| Proprietary Name: | Safetussin |
| Non Proprietary Name: | Dextromethorpan Hydrobromide Guaifenesin |
| Active Ingredient(s): | 30; 200 mg/10mL; mg/10mL & nbsp; Dextromethorpan Hydrobromide Guaifenesin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55505-137 |
| Labeler Name: | Kramer Laboratories |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part341 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20101209 |
| Package NDC: | 55505-137-20 |
| Package Description: | 120 mL in 1 BOTTLE, PLASTIC (55505-137-20) |
| NDC Code | 55505-137-20 |
| Proprietary Name | Safetussin |
| Package Description | 120 mL in 1 BOTTLE, PLASTIC (55505-137-20) |
| Product NDC | 55505-137 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Dextromethorpan Hydrobromide Guaifenesin |
| Dosage Form Name | LIQUID |
| Route Name | ORAL |
| Start Marketing Date | 20101209 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Kramer Laboratories |
| Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN |
| Strength Number | 30; 200 |
| Strength Unit | mg/10mL; mg/10mL |
| Pharmaceutical Classes |